Theresa Lamagni
UK Health Security Agency, UK, United Kingdom
- This delegate is presenting an abstract at this event.
Dr Theresa Lamagni MSc PhD HonMFPH
Dr Theresa Lamagni is a Section Head Healthcare-Associated Infection & Antimicrobial Resistance Division of the UK Health Security Agency and designated epidemiologist for the WHO Collaborating Centre for Streptococcal Diseases. She has worked in public health for over 25 years. During this time, she completed an MSc in Epidemiology at the London School of Hygiene & Tropical Medicine and a PhD at the University of Helsinki. Theresa has strategic responsibility for surveillance of streptococcal diseases in England, providing expert support to outbreak and incident response and contributing to the development of an evidence base to inform disease prevention programmes. She has authored over 190 peer-review papers, four clinical microbiology book chapters and four national public health guidelines and sits on the editorial board of the Journal of Antimicrobial Chemotherapy.
Presentations this author is a contributor to:
Effecting control of a widespread emm11 GAS outbreak linked to community healthcare services in the East of England, 2023-25 (#132)
5:30 PM
Theresa Lamagni
Poster Session 1
Investigating differential maternal GBS carriage according to ethnicity: cross-sectional analysis nested within a multicentre randomised clinical trial in England (#131)
5:30 PM
Theresa Lamagni
Poster Session 1
Evaluating the epidemiology of severe cellulitis and household risk of secondary iGAS infection in England: 2015-2022 (118191)
11:27 AM
Eleanor Blakey
Plenary 8 - Surveillance, Transmission, and Public Health Interventions
Rare deleterious variants and susceptibility to invasive group A streptococcal disease (118320)
10:15 AM
Tom Parks
Plenary 10 - Invasive Disease
Implementation of whole genome sequencing (WGS) replacing targeted emm gene sequencing in informing Group A Streptococcus pyogenes (GAS) outbreaks (#257)
5:30 PM
Kartyk Moganeradj
Poster Session 2
Distribution of serotype and protein vaccine targets in disease-causing GBS in the UK (2009-2023): implications for GBS vaccine rollout (118005)
4:05 PM
Elita Jauneikaite
Plenary 4 - Rapid Fire Session
Descriptive analysis of incidence, hospital acquisition and health inequalities in invasive group C and G streptococcal infections England, 2016 to 2023 (#123)
5:30 PM
Rebecca L Guy
Poster Session 1
Streptococcal brain abscesses: assessing a decade of trends in England between 2014 and 2023 (#124)
5:30 PM
Rebecca L Guy
Poster Session 1
Exposing inequalities in streptococcal infection in a high income setting (124652)
4:00 PM
Theresa Lamagni
Concurrent 2b - Epidemiology